Javascript must be enabled to continue!
Structural and functional insight of Mobilized Colistin Resistance-1 variants
View through CrossRef
Mobilized Colistin Resistance-1 (MCR-1) is a transferase enzyme that
confers resistance to polypeptide antimicrobial called colistin
(polymyxin E) by modifying lipid A of the Gramnegative bacterial cell
membrane. The rapid dissemination of MCR-1 and its variants has become a
public health concern. So far, thirty-six variants of MCR-1 have been
reported across the world. These variants have been detected in 109
different bacterial species. They differ from each other either by
single (29 variants) or multiple (7 variants) substitutions. These
substitutions mostly occur in the transmembrane domain of MCR-1. While
the MCR-1 is 91% conserved overall, the catalytic domain is more stable
with 93.6% of the residues unchanged. In this review, we have
summarized the crystal structure of MCR-1 and provided a comparative
analysis of all mutants. Besides, we have highlighted the differing
amino acid substitutions in the two domains of MRC-1 and in the α-helix,
β-sheets, and loops of cMRC. Moreover, we have focused on residues that
may have a role in catalysis and can be exploited as potential drug
targets. The impact of these changes and the function of active site
residues need to be thoroughly understood to design drugs that are
effective against all the variants of MCR-1.
Title: Structural and functional insight of Mobilized Colistin Resistance-1 variants
Description:
Mobilized Colistin Resistance-1 (MCR-1) is a transferase enzyme that
confers resistance to polypeptide antimicrobial called colistin
(polymyxin E) by modifying lipid A of the Gramnegative bacterial cell
membrane.
The rapid dissemination of MCR-1 and its variants has become a
public health concern.
So far, thirty-six variants of MCR-1 have been
reported across the world.
These variants have been detected in 109
different bacterial species.
They differ from each other either by
single (29 variants) or multiple (7 variants) substitutions.
These
substitutions mostly occur in the transmembrane domain of MCR-1.
While
the MCR-1 is 91% conserved overall, the catalytic domain is more stable
with 93.
6% of the residues unchanged.
In this review, we have
summarized the crystal structure of MCR-1 and provided a comparative
analysis of all mutants.
Besides, we have highlighted the differing
amino acid substitutions in the two domains of MRC-1 and in the α-helix,
β-sheets, and loops of cMRC.
Moreover, we have focused on residues that
may have a role in catalysis and can be exploited as potential drug
targets.
The impact of these changes and the function of active site
residues need to be thoroughly understood to design drugs that are
effective against all the variants of MCR-1.
Related Results
P-1233. Application of Pharmacometrics in the Personalized Colistin Dosing Recommendation
P-1233. Application of Pharmacometrics in the Personalized Colistin Dosing Recommendation
Abstract
Background
Colistin is frequently used as a treatment for infections caused by carbapenem-resistant Gram-negative bacte...
Flavomycin restores colistin susceptibility in multidrug-resistant Gram-negative bacteria
Flavomycin restores colistin susceptibility in multidrug-resistant Gram-negative bacteria
ABSTRACT
Polymyxin is used as a last resort antibiotics for infections caused by multi-drug resistant (MDR) Gram-negative bacteri...
Comparing Quantitative and Qualitative Methods for Detecting the In Vitro Activity of Colistin against Different Gram-Negative Bacilli
Comparing Quantitative and Qualitative Methods for Detecting the In Vitro Activity of Colistin against Different Gram-Negative Bacilli
The surge in the prevalence of Multidrug-Resistant (MDR) Gram-negative bacterial infections with limited treatment led to colistin reusing to treat MDR infections. This study aimed...
Acquisition of Colistin Resistance Links Cell Membrane Thickness Alteration with a Point Mutation in the lpxD Gene in Acinetobacter baumannii
Acquisition of Colistin Resistance Links Cell Membrane Thickness Alteration with a Point Mutation in the lpxD Gene in Acinetobacter baumannii
Acinetobacter baumannii is one of the most common causes of nosocomial infections in intensive care units. Its ability to acquire diverse mechanisms of resistance limits the therap...
Comprehensive proteomic and metabolomic profiling of mcr-1 mediated colistin resistance in Escherichia coli
Comprehensive proteomic and metabolomic profiling of mcr-1 mediated colistin resistance in Escherichia coli
AbstractThe spread of mcr-1 in human and veterinary medicine has jeopardized the use of polymyxins, the last-resort antibiotics against life-threatening multidrug-resistant Gram-ne...
Comparison of Available Methods for Investigating The in vitro Activity of Colistin Against Different Gram-Negative Bacilli
Comparison of Available Methods for Investigating The in vitro Activity of Colistin Against Different Gram-Negative Bacilli
Background: The surge in the prevalence of multidrug-resistant (MDR) Gram-negative bacterial infections with limited treatment options and the decrease in the development of new an...
A quantitative method for determination of colistin E2 methane sulphonate sodium (CMS E2) in human plasma by 15N-labeled colistin E2
A quantitative method for determination of colistin E2 methane sulphonate sodium (CMS E2) in human plasma by 15N-labeled colistin E2
Abstract
The single-component colistin E2, with superior antibacterial activity and lower toxicity, was being developed as the latest generation of polymyxin drugs. However...
Prevalence of colistin resistance in multidrug-resistant Klebsiella pneumoniae recovered from clinical samples in Africa: a systematic review and meta-analysis
Prevalence of colistin resistance in multidrug-resistant Klebsiella pneumoniae recovered from clinical samples in Africa: a systematic review and meta-analysis
Abstract
Background
Colistin resistance in multidrug-resistant (MDR) Klebsiella pneumoniae is a growing concern in Africa, compl...

